Polymeric matrices for the encapsulation of phosphorescent molecules for analytical applications
View Patent ↗The invention involves encapsulation of phosphorescent molecules in polymeric matrices to prevent phosphorescence quenching. Specifically, polymers containing a significant portion of halogens have been found to be good matrices for encapsulation of phosphorescent molecules to provide strong phosphorescence at ambient conditions. Those encapsulated phosphorescent molecules can find a wide variety of applications for detection of many species, including biological and chemical molecules as well as micro-organisms.
1. A phosphorescent particle comprising a phosphorescent material encapsulated in a halogen-containing polymer, wherein the size of the particle is from about 10 nanometers to about 10 micrometers.
2. The particle of claim 1 where the phosphorescence can be detected by an unaided human eye.
3. The particle of claim 1 where the halogen-containing polymer that encapsulates the phosphorescent material contains between 5 and 90 weight percent halogen.
4. The particle of claim 1 where the halogen-containing polymer that encapsulates the phosphorescent material contains between 30 and 70 weight percent halogen.
5. The particle of claim 4 wherein said halogen-containing polymer is selected from the group consisting of polyvinyl fluoride, polyvinyl chloride, polyvinyl bromide and mixtures thereof.
6. The particle of claim 1 where the halogen-containing polymer has the general structure:
where at least one of X 1 -X 4 contains one or more halogen atoms.
7. The particle of claim 1 where the phosphorescence material is a metal chelate.
8. The particle of claim 7 where the phosphorescent material is selected from the group consisting of bis[(4,4′-carbomethoxy)-2,2′-bipyridine]2-[3- -(4-methyl-2,2′-bipyridine-4-yl)propyl]-1,3-dioxolane ruthenium (II); bis(2,2′bipyridine)[4-(butan-1-al)-4′-methyl-2,2′-bi-pyridine]ruthenium (II); bis(2,2′-bipyridine)[4-(4′-methyl-2,2′-bipyridine-4′-yl)-butyric acid]ruthenium (II); tris(2,2′bipyridine)ruthenium (II); (2,2′-bipyridine) [bis-bis(1,2-diphenylphosphino)ethylene]2-[3-(4-methyl-2,2′-bipyridine-4′-yl)propyl]-1,3-dioxolane osmium (II); bis(2,2′-bipyridine)[4-(4′-methyl-2,2′-bipyridine)-butylamine]ruthenium (II); bis(2,2′-bipyridine)[1-bromo-4(4′-methyl-2,2′-bipyridine-4-yl)butan-e]ruthenium (II); bis(2,2′-bipyridine)maleimidohexanoic acid, 4-methyl-2,2′-bipyridine-4′-butylamide ruthenium(II), platinum (II) tetra-meso-fluorophenylporphine (Pt-TMFPP), and palladium (II) tetra-meso-fluorophenylporphine (Pd-TMFPP).
9. A phosphorescent particle comprising a halogen-containing polymer encapsulating a phosphorescent material, wherein said halogen-containing polymer has at least one surface functional group, wherein the size of the particle is from about 10 nanometers to about 10 micrometers.
10. The particle of claim 9 wherein said surface functional group is a hydrophilic group selected from the group consisting of carboxylic acid groups, ethanolamine groups, hydroxyl groups, amine groups, amino groups, imine group and polyethylene glycol groups.
11. The particle of claim 9 wherein said halogen-containing polymer is poly(vinyl chloride-co-vinyl acetate-co-maleic acid).
12. The particle of claim 1 , wherein the size of the particle is from about 50 nanometers to about 1 micrometer.
13. The particle of claim 1 , wherein the size of the particle is from about 150 nanometers to about 500 nanometers.
14. The particle of claim 9 , wherein the size of the particle is from about 50 nanometers to about 1 micrometer.
15. The particle of claim 9 , wherein the size of the particle is from about 150 nanometers to about 500 nanometers.
16. The particle of claim 1 , wherein the particle is attached to an antibody.
17. The particle of claim 9 , wherein the particle is attached to an antibody.